Dual-target Chimeric Antigen Receptor T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual-target Chimeric Antigen Receptor T Cells, covering 2025-06-18 to 2025-06-18. Get the full timeline:
Most recent: Clinical Trial Update: To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors [Phase 1]